[Federal Register Volume 87, Number 246 (Friday, December 23, 2022)]
[Notices]
[Pages 78986-78987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27955]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the National Advisory 
Allergy and Infectious Diseases Council.
    The meeting will be open to the public. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (http://videocast.nih.gov). Individuals who need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council.
    Date: January 30, 2023.
    Open: 10:30 a.m. to 11:30 a.m.
    Agenda: Report of Institute Acting Director.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Closed: 11:45 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Room 4F30, 5601 Fishers Lane, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division 
of Extramural Activities, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 4F50, Bethesda, MD 20892, 301-496-7291, 
[email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Allergy, Immunology and Transplantation 
Subcommittee.
    Date: January 30, 2023.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division 
of Extramural Activities, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 4F50 Bethesda, MD 20892, 301-496-7291, 
[email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
    Date: January 30, 2023.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division 
of Extramural Activities, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 4F50, Bethesda, MD 20892, 301-496-7291, 
[email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council, Acquired Immunodeficiency Syndrome Subcommittee.
    Date: January 30, 2023.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of

[[Page 78987]]

Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual 
Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division 
of Extramural Activities, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 4F50, Bethesda, MD 20892, 301-496-7291, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice at least 10 days in advance of the meeting. The 
statement should include the name, address, telephone number and 
when applicable, the business or professional affiliation of the 
interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.niaid.nih.gov/about/advisory-council, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 19, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-27955 Filed 12-22-22; 8:45 am]
BILLING CODE 4140-01-P